This anatomical distinction suggests that GIPRAs and GLP-1RAs act on different neuronal circuits, and their signals may be integrated within the brain, leading to synergistic anti-obesity effects
The study mentioned above, published in November of 2023, analyzed 12,136 comments on Reddit, 17,059 TikTok videos, and 14,515 Youtube videos mentioning certain GLP-1 receptor agonists (including Ozempic), finding the most common matches (620) related to insomnia and sleep problems
On the other hand, beneficial metabolites such as butyrate can activate cellular mechanisms for protein clearance: butyrate readily crosses the BBB and can inhibit histone deacetylases, thereby activating gene expression programs that enhance autophagy and reduce toxic protein aggregates [55]
Both medications are injectable GLP-1 receptor agonists used for type 2 diabetes management and weight loss, but they have several important differences: Mounjaro (tirzepatide) : Functions as both a GIP and GLP-1 receptor agonist, targeting two hormone pathways Ozempic (semaglutide) : Works solely as a GLP-1 receptor agonist, targeting one hormone pathway Based on the Phase 3 SURPASS-2 clinical study: Mounjaro : Approved for type 2 diabetes Ozempic : Approved for: Mounjaro : Ozempic : For expats and travelers in Mexico, both medications require a prescription, but Mounjaro may be preferred by those seeking more significant weight loss or better glycemic control
However, the principle of GLP-1 regulating BP is still not fully understood